Beludavimab is a Monoclonal Antibody Targeting SARS-CoV-2 Spike Glycoprotein
SARS‑CoV‑2 (Severe acute respiratory syndrome coronavirus 2) is a strain of coronavirus. However, SARS‑CoV‑2 has caused on going COVID-19 (coronavirus disease 2019) pandemic and led to a serious threat to…